Table 1.
General clinical and pathological characteristics of female dogs with CMGTs.
| Characteristics | Number | Frequency (%) |
|---|---|---|
| Control group | 38 | |
| Ages | ||
| ≥ 8 | 20 | 52.63 |
| < 8 | 18 | 47.37 |
| Benign tumor group | 60 | |
| Ages | ||
| ≥ 8 | 32 | 53.33 |
| < 8 | 28 | 46.67 |
| Size (cm) | ||
| T1 (< 3) | 26 | 43.33 |
| T2 (3 ≤ T ≤ 5) | 20 | 33.33 |
| T3 (> 5) | 14 | 23.33 |
| Histrogical type | ||
| Fibroadenoma | 18 | 30.00 |
| Intraductal papillary adenoma | 13 | 21.67 |
| Simple adenoma | 4 | 6.67 |
| Hyperplasia/dysplasia(duct ectasia, lobular hyperplasia and epitheliosis) | 19 | 31.66 |
| Others | 6 | 10 |
| Malignant tumor group | 52 | |
| Ages | ||
| ≥ 8 | 18 | 34.62 |
| < 8 | 34 | 65.38 |
| Size (cm) | ||
| T1 (< 3) | 8 | 15.38 |
| T2 (3 ≤ T ≤ 5) | 27 | 51.92 |
| T3 (> 5) | 17 | 32.69 |
| Histrogical type | 52 | |
| Simple carcinoma | 28 | 53.84 |
| Solid carcinoma | 12 | 23.07 |
| Intraductal papillary carcinoma | 5 | 9.62 |
| Invasive micropapillary carcinoma | 2 | 3.85 |
| Carcinoma in situ | 2 | 3.85 |
| Others carcinoma | 3 | 5.77 |
| Histologic grade | ||
| I | 16 | 30.77 |
| II | 24 | 46.15 |
| III | 12 | 23.08 |
| Molecular subtype | ||
| Luminal A | 14 | 26.92 |
| Luminal B | 24 | 46.15 |
| Her-2 positive | 8 | 15.38 |
| Basal-like | 6 | 11.54 |